The Hyperion Fund functions as a syndicated venture capital fund that provides independent investors access to the earliest stages of investing in blockchain projects. Through the IHF token, investors gain diversified exposure to a portfolio of expertly-vetted investments in private and public pre-sales, and ICOs. Invictus analysts leverage proprietary analysis tools (such as the Titan AI tool) to navigate the higher risk characteristic of these early-stage investments.
The STEM CELL PROJECT team created a special technology to quickly and accurately produce STEM cells for batch processing. By further expanding this technology and optimizing the cost of stem cell therapy, SCC’s goal is to create an environment where people who really need regenerative medicine can receive this treatment on an equal footing.